RPGR and RP2: targets for the treatment of X-linked retinitis pigmentosa?

Author： Veltel Stefan   Wittinghofer Alfred  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.13, Iss.10, 2009-10, pp. : 1239-1251

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular Biology of Retinitis Pigmentosa: Therapeutic Implications

By  

Current Pharmacogenomics, Vol. 2, Iss. 4, 2004-12 ,pp. : 339-349

Bentham Science Publishers

Access to resources Recommend Favorite

X-linked inhibitor of apoptosis protein as a therapeutic target

By Dean Emma J   Ranson Malcolm   Blackhall Fiona   Dive Caroline  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 11, 2007-11 ,pp. : 1459-1471

Informa Healthcare

Access to resources Recommend Favorite

Preimplantation genetic diagnosis of X-linked retinoschisis

By Lledó Belén   Ten Jorge   Rodriguez-Arnedo Dori   Llácer Joaquín   Bernabeu Rafael  

Reproductive BioMedicine Online, Vol. 16, Iss. 6, 2008-06 ,pp. : 886-892

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Potential Application of Gene Therapy to X-Linked Agammaglobulinemia

By  

Current Gene Therapy, Vol. 7, Iss. 4, 2007-08 ,pp. : 284-294

Bentham Science Publishers

Access to resources Recommend Favorite

Oxaliplatin: First report of worsened retinitis pigmentosa: case report

By  

Reactions Weekly, Vol. 1, Iss. 1400, 2012-01 ,pp. : 32-32

Adis International

Access to resources Recommend Favorite